Reimbursed with a limitationOriginator productATC B02BD02

Elocta

Elocta is an originator product from Swedish Orphan Biovitrum AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 232.20 to CHF 3'099.35 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Swedish Orphan Biovitrum AG
ATC code
B02BD02
IT group
06.01.10 Blutkonserven und Plasmafraktionen
Active substances
Efmoroctocogum alfa
Preparation type
Originator product
On the SL since
01/08/2016
Last price change
01/02/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Elocta Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Trockensub 250 IE c SolvSet 1 StkCHF 186.30CHF 232.2001/06/2024B7680658430010
Trockensub 500 IE c SolvSet 1 StkCHF 372.60CHF 423.3501/06/2024B7680658430027
Trockensub 1000 IE c SolvSet 1 StkCHF 745.20CHF 805.6501/06/2024B7680658430041
Trockensub 1500 IE c SolvSet 1 StkCHF 1'117.80CHF 1'187.9001/06/2024B7680658430058
Trockensub 2000 IE c SolvSet 1 StkCHF 1'490.40CHF 1'570.2001/06/2024B7680658430065
Trockensub 3000 IE c SolvSet 1 StkCHF 2'235.60CHF 2'334.7501/06/2024B7680658430072
Trockensub 4000 IE c SolvSet 1 StkCHF 2'980.80CHF 3'099.3501/06/2024B7680658430089

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/06/2024

Behandlung und Prophylaxe von Blutungen bei vorbehandelten Patienten mit Hämophilie A (kongenitaler Faktor-VIII-Mangel).
ELOCTA enthält keinen von-Willebrand-Faktor und ist daher nicht für die Behandlung von Patienten mit von-Willebrand-Syndrom indiziert.

FOPH wordingValid from 01/05/2014

Preisberechnung für Blutpräparate aufgrund des Fabrikabgabepreises zuzüglich einer Fixmarge wegen der speziellen Verteilersituation (praktisch kein Zwischenhandel) von Fr. 40.-- zuzüglich MWST. Diese Berechnung gilt nicht für die Humanalbumine.

More preparations in this group

FAQ

Is Elocta covered by Swiss health insurance?

Yes, but only under conditions. Elocta is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Elocta cost in Switzerland?

The public price is the maximum price set by the FOPH and for Elocta ranges from CHF 232.20 to CHF 3'099.35 per pack. The ex-factory price ranges from CHF 186.30 to CHF 2'980.80. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com